ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
4.938
-0.137
(-2.70%)
Cerrado 12 Noviembre 10:30AM
Realtime Data

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
4.938
Postura de Compra
4.938
Postura de Venta
4.952
Volume Operado de la Acción
4,384
4.934 Rango del Día 5.025
0.00 Rango de 52 semanas 0.00
Precio Anterior
5.075
Precio de Apertura
5.005
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
21,752 €
Precio Promedio Ponderado
4.9616

PBBD Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ERTDEl Arts Inc Dl 01
152.32 €
(28.82%)
6
BLCHDGlobal X ETF ICAV
13.782 €
(27.49%)
850
MDFEDuro Felguera SA
0.514 €
(27.07%)
24.59k
NWTDWells Fargo & Co
68.27 €
(16.90%)
299
TM5DT Mobile USA Inc
223.50 €
(14.66%)
44
ATOPAtos SE
0.379 €
(-42.75%)
47.12k
BIOSBBiosenic
0.0068 €
(-34.62%)
32
EBUSAEbusco Holding NV
1.6492 €
(-21.47%)
2.62k
XANOBSXano Industrier AB
SEK 57.70
(-20.30%)
1.46k
UTDIDUnited Internet AG
15.62 €
(-17.88%)
127.83k
TITMTelecom Italia SpA
0.2172 €
(-3.81%)
7.61M
TITRMTelecom Italia
0.256 €
(-1.95%)
5.1M
ISPMIntesa Sanpaolo Spa
3.8035 €
(-2.55%)
3.2M
ENELMEnel Spa
6.591 €
(-2.20%)
1.92M
SPMMSaipem Spa
2.318 €
(-1.65%)
1.5M
The_Gman The_Gman 5 minutos hace
Space. The difference between witnessing a kid napping....and a kidnapping.

Yeah, that's where the pic came from.
NB
ignatiusrielly35 ignatiusrielly35 5 minutos hace
You have no information as to when specifically the ATM is used. Period. In fact, I recall you attributing a price dip earlier this year to dilution in one quarter and the 10q showed virtually none. I repeat, blind guess.
AVXL
12yearplan 12yearplan 6 minutos hace
Sorry for the late reply; .. from your two links and thanks..
 
Summary.
 
Since the early 1970s, hourly inflation-adjusted wages received by the typical worker have barely risen, growing only 0.2% per year. Assigning relative responsibility to the policies and economic f
navycmdr navycmdr 6 minutos hace
https://x.com/InvestIt3/status/1856406733754708460
FNMA
2B_unknown 2B_unknown 6 minutos hace
Yes, we have had the golden ticket for some time now:)

We got this thing, just a matter of time.
NWBO
Hosai Hosai 6 minutos hace
From what I can see based on historical EMA review start dates in late 22 and 23 and aided by chat GPT it guesses the last 2 EMA review start dates for 2024 will be Nov 28th and Dec 27th.
If Anavex were to be aiming for the Nov 28th (ish) it would need to submit any time now. Obv though even
AVXL
MartinLutherKing MartinLutherKing 6 minutos hace
It just hit the wires brother
https://www.forbes.com/sites/jessicaourisman/2024/11/12/the-firsthand-results-of-a-nanofat-treatment-using-stem-cells-and-prp/
ELAB
manibiotech manibiotech 6 minutos hace
Yep nothing for market to be in any FOMO mode 
Likely will slowly go down over next few days without news . As I also said after ASM
ASM
Groveman1 Groveman1 7 minutos hace
Lucky, There's a new response on StockRunners twitter site today 11/12/24 on LLBO. Please check it and see if you can understand what this means for LLBO. StockRunners talks about attorneys and filing papers, but seems to be speaking about the other Company attached to the Post. Check it out.
LLBO
FeMike FeMike 7 minutos hace
I think they would rather say the inspection is completed even if the 10-q is up to September 30 only. If it's done by now since the q was prepared this nov. Therefore, it is not completed up to now.

My personal opinion is that saying "the inspections have been completed" is a bit too
NWBO
cottonisking cottonisking 7 minutos hace
No, peanuts and small money, compared to this board waiting here since 2008 and going through United States' Presidents and nut cases. Shut this mental ward down now. These guys have nothing better to do. Most must be in their 80s.
LEHNQ
northam43 northam43 7 minutos hace
Report #2 October 2024 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2024/11/12/inz[o2_Completed_Cycles.PNG
manibiotech manibiotech 8 minutos hace
Look at section subsequent events in 10 q

Hmm
NWBO
jimr1717 jimr1717 8 minutos hace
New Tesla Involved in a Crash While on FSD, the Teslacam Footage Was All Police Needed
3 Nov 2024, 22:00 UTC •

Bob claims that the moment the pickup truck slammed into his rear end, the FSD turned the steering wheel to the left to prevent his Tesla from hitting the vehicle wait
TSLA
MRJ25 MRJ25 8 minutos hace
Reddit will be better.
FNMA
Rebel13 Rebel13 9 minutos hace
There’s a saying about not being able to find your a$$ even if handed to you. Didn’t realize you were real!
ELTP
art2426 art2426 9 minutos hace
We're not getting into politics? Really? Who exactly brought THIS up? ---- "Especially with the new pro small business President we just elected!"


How is reading this board, NOT FUN?
BIEL
jimr1717 jimr1717 9 minutos hace
How? Watch and learn.
TSLA
mrwrn2010 mrwrn2010 10 minutos hace
Blast from the past!
ELTP
Mactheriverrat Mactheriverrat 10 minutos hace
Thoughts on TLRY?
TLRY
exwannabe exwannabe 10 minutos hace
Reimbursement. The Company has evaluated and selected specialized, highly experienced consultants with whom to undertake preparations for a potential reimbursement review ...
In other words, not even close to submitting the evidence that kicks off the NICE process.
NWBO
gdog gdog 11 minutos hace
11-12 buy/cover EVH $14.19 + 4.15%
MahinAgency MahinAgency 11 minutos hace
H.C. Wainwright maintains a "Buy" rating for Cardiol Therapeutics with a price target of $9.00.

MAVERIC-2 trial aims to assess CardiolRx in recurrent pericarditis patients post-IL-1 blocker therapy.
CRDL
againstallodds againstallodds 11 minutos hace
Market expects gold delivery, imagine if no delivery

No gold = no created value
NBRI
CommodityCoverage CommodityCoverage 11 minutos hace
Developing therapeutic compounds for pediatric diseases with unmet medical needs and a large addressable market, clinical-stage biotech company Thiogenesis Therapeutics (TTI.v), recently announced the approval of its European patent for the treatment of Cysteamine Sensitive Disorders, a medical cond
TTI

Su Consulta Reciente

Delayed Upgrade Clock